Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report)’s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.13 and traded as high as $0.22. Enzon Pharmaceuticals shares last traded at $0.20, with a volume of 94,897 shares changing hands.
Enzon Pharmaceuticals Trading Up 11.0 %
The company has a market capitalization of $14.84 million, a price-to-earnings ratio of 20.02 and a beta of 0.49. The firm’s 50-day moving average price is $0.11 and its 200 day moving average price is $0.13.
About Enzon Pharmaceuticals
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
Further Reading
- Five stocks we like better than Enzon Pharmaceuticals
- Learn Technical Analysis Skills to Master the Stock Market
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Earnings Per Share Calculator: How to Calculate EPS
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
